Particularly, the enhanced predictive value of hs-cTnT aligns with previous research suggesting that biomarkers – especially cardiac biomarkers – as demonstrated by studies [14–16,26,41], may significantly contribute to risk stratification for AF patients. This evidence concerns the gene TNNT2 and atrial fibrillation.